Skip to content
Home/Companies/MedTech/Irrimax

Irrimax

MedTech·US·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Irrimax?

Irrimax is currently owned by ARCHIMED through MED Rise (2024 vintage), since 2024.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Rise · 2024 · Buyout

Key facts

HQUnited States
SectorMedTech

More from MED Rise

Other portfolio companies in the same fund.

IRAB
IRAB
Active
PharmaSpain· 2026
Arkstone
Active
HealthTechUS· 2025
Ceva Animal Health
Ceva Animal Health
Active
PharmaFrance· 2025
ExcellGene
ExcellGene
Active
BiotechSwitzerland· 2025
Groupe Laboratoire Rivadis
Active
HealthTechFrance· 2025
ZimVie
ZimVie
Active
MedTechUS· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Irrimax

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Irrimax?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Irrimax.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue